Jump Financial, LLC Tango Therapeutics, Inc. Transaction History

Jump Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.51 - $12.88 $161,419 - $276,842	21,494 New	21,494 $170,000
Q1 2023 Oct 21, 2024	BUY	$3.76 - $8.06 $47,067 - $100,895	12,518 New	12,518 $49,000
Q1 2023 May 03, 2023	SELL	$3.76 - $8.06 $20,804 - $44,595	-5,533 Reduced 30.65%	12,518 $49,000
Q4 2022 Feb 13, 2023	BUY	$3.41 - $8.29 $15,382 - $37,396	4,511 Added 33.32%	18,051 $130,000
Q3 2022 Nov 07, 2022	BUY	$3.25 - $5.46 $44,005 - $73,928	13,540 New	13,540 $49,000

123

91.7M

3.1K

1.5K

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $268M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.